Literature DB >> 29577555

Transanal endoscopic surgery is effective and safe after endoscopic polypectomy of potentially malignant rectal polyps with questionable margins.

X Serra-Aracil1, A Pallisera-Lloveras1, L Mora-Lopez1, S Serra-Pla1, V Puig-Diví2, À Casalots3, E Martínez-Bauer2, S Navarro-Soto1.   

Abstract

AIM: To determine the percentage of residual lesion observed in the pathology study of transanal endoscopic surgery (TEM) specimens after endoscopic polypectomy of malignant rectal polyps with questionable margins, and the need for further surgery. Secondary aims: to determine the morbidity and mortality associated with this procedure and to identify the percentage of recurrence after excision by TEM.
METHODS: Observational study with prospective data collection of all patients undergoing TEM after endoscopic polypectomy for malignant rectal polyps or non-invasive high-grade neoplasia, from January 2004 to December 2016. An en bloc full-thickness wall excision of the scar was performed. Variables recorded: histology of TEM specimen, 30-day morbidity and mortality according to the Clavien-Dindo classification, need for salvage surgery and recurrence.
RESULTS: Fifty out of 690 patients undergoing TEM during the study period (36 adenocarcinomas, five non-invasive high-grade neoplasias and 9 neuroendocrine tumors) were included. Post-surgery histology showed residual lesion in 21 (42%) patients: 7 neuroendocrine tumors, 10 adenomas and 4 adenocarcinomas (two pT1, one pT2 and one pT3). The pT2 and pT3 patients (4%) underwent salvage surgery. No recurrence was observed, and mean follow-up was 29.1Â ± 21.6 months. The 30-day morbidity rate was 14%, but 4/7 with Clavien-Dindo grade I.
CONCLUSIONS: After endoscopic polypectomy of malignant rectal polyps with questionable margins, the presence of residual lesion in the pathology study of transanal resection specimens is high. TEM with full-thickness resection of these lesions is an appropriate treatment, allowing disease control and achieving minimal morbidity. Colorectal Disease
© 2018 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Transanal endoscopic surgery; endoscopic polypectomy; fullthickness rectal wall excision; malignant rectal polyp

Mesh:

Year:  2018        PMID: 29577555     DOI: 10.1111/codi.14108

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  6 in total

1.  Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience.

Authors:  Nico Pagano; Claudio Ricci; Nicole Brighi; Carlo Ingaldi; Francesco Pugliese; Donatella Santini; Davide Campana; Cristina Mosconi; Valentina Ambrosini; Riccardo Casadei
Journal:  Endocrine       Date:  2019-03-27       Impact factor: 3.633

Review 2.  The Role of Transanal Endoscopic Surgery for Early Rectal Cancer.

Authors:  Natalie F Berger; Patricia Sylla
Journal:  Clin Colon Rectal Surg       Date:  2022-02-28

3.  Assessment of clinical and pathological complete response after neoadjuvant chemoradiotherapy in rectal adenocarcinoma and its therapeutic implications.

Authors:  Sorin Tiberiu Alexandrescu; Adrian Vasile Dumitru; Ruxandra Doina Babiuc; Radu Virgil Costea
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

4.  Transanal endoscopic microsurgery after the attempt of endoscopic removal of rectal polyps.

Authors:  Monica Ortenzi; Alberto Arezzo; Roberto Ghiselli; Marco Ettore Allaix; Mario Guerrieri; Mario Morino
Journal:  Surg Endosc       Date:  2022-03-04       Impact factor: 3.453

Review 5.  International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer.

Authors:  Emmanouil Fokas; Ane Appelt; Alexandra Gilbert; David Sebag-Montefiore; Claus Rödel; Robert Glynne-Jones; Geerard Beets; Rodrigo Perez; Julio Garcia-Aguilar; Eric Rullier; J Joshua Smith; Corrie Marijnen; Femke P Peters; Maxine van der Valk; Regina Beets-Tan; Arthur S Myint; Jean-Pierre Gerard; Simon P Bach; Michael Ghadimi; Ralf D Hofheinz; Krzysztof Bujko; Cihan Gani; Karin Haustermans; Bruce D Minsky; Ethan Ludmir; Nicholas P West; Maria A Gambacorta; Vincenzo Valentini; Marc Buyse; Andrew G Renehan
Journal:  Nat Rev Clin Oncol       Date:  2021-08-04       Impact factor: 66.675

6.  Oncological outcome after local treatment for early stage rectal cancer.

Authors:  Caroline D M Witjes; Abhilashaben S Patel; Aniruddh Shenoy; Stephen Boyce; James E East; Christopher Cunningham
Journal:  Surg Endosc       Date:  2021-02-05       Impact factor: 4.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.